They discuss the biochemistry and cell biology of 
amyloid beta-protein precursor, tau, presenilin, beta-secretase, and apolipoprotein E and their involvement in the disease, as well as its clinical, neuropathological, imaging, and biomarker phenotypes; associated genetic alterations; and epidemiological insights into its cause and pathogenesis.